复苏性主动脉腔内球囊阻断术在早期抗休克治疗中的应用及进展  

Application and progress of resuscitative endovascular balloon occlusion of the aorta(REBOA)in early anti-shock therapy

作　　者：张昊 陆清声 Zhang Hao;Lu Qingsheng(Department of Vascular Surgery,Changhai Hospital affiliated to PLA Navy Military Medical University,Shanghai 200433,China)

机构地区：[1]中国人民解放军海军军医大学附属长海医院血管外科,上海200433

出　　处：《中华胸心血管外科杂志》2020年第10期637-640,共4页Chinese Journal of Thoracic and Cardiovascular Surgery

摘　　要：复苏性主动脉腔内球囊阻断术(REBOA)是早期抗休克的重要技术方法,能够快速实现有效止血、维持基础血压、保证、脑等重要脏器的供血,提高患者抗休克救治成功率。但是由于REBOA可能引起远端严重缺血等并发症,限制了其使用。随着临床认识的进步和抗休克救治理念的不断提高,REBOA有了重大进展,包括pREBOA和iREBOA的使用,在心脏骤停情况的使用等。为了更好的使用REBOA,需要进一步深入研究,建立完善的医疗救治制度和培训体系,最大程度发挥其作用。Resuscitative endovascular balloon occlusion of the aorta(REBOA)is an important technical method for early anti-shock.It can quickly achieve effective hemostasis,maintain basic blood pressure,ensure blood supply to important organs such as the brain,and improve the success rate of anti-shock treatment.However,the use of REBOA is limited because it can cause complications such as severe distal ischemia.With the improvement of clinical awareness and the continuous improvement of anti-shock treatment concept,REBOA has made significant progress,including the use of pREBOA and iREBOA,and the use in cardiac arrest.In order to make better use of REBOA,further in-depth research is needed to establish a comprehensive medical treatment system and training system to maximize its role.

关 键 词：基础血压 主动脉腔 临床认识 抗休克 心脏骤停 球囊阻断术 复苏 培训体系 

分 类 号：R654.3[医药卫生—外科学] R459.7[医药卫生—临床医学]